Congratulations to Dr.Timothy Garret! His article is among the top 10% most cited PLOS ONE papers published in 2019. “Metabolomic profiling of oxalate-degrading probiotic Lactobacillus acidophilus and Lactobacillus gasseri” CITED 13 TIMES as of July 2021…
ASCP’s 40 Under Forty Program Recognizes a New Generation of Laboratory Leaders JUNE 2021—Robert P. Seifert of the University of Florida, College of Medicine, Department of Pathology, Immunology and Laboratory Medicine, Gainesville, FL is among 40 high-achieving pathologists, pathology residents, and medical laboratory professionals under age 40 who have just…
We had 379 votes this year in our photo contest! Way to spread the love of pathology! Congratulations to our top 3 winners. #1. A Night Scene by Nada Al Qaysi #2. Eye Love Pathology by Nichole Allen #3. The Last Tree by Zhongbo Jin…
Iqbal Mahmud Recognized for Publishing a Most Accessed Articles from Journal of the American Society for Mass Spectrometry Dr. Iqbal Muhmud’s paper Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives has been recognized as one of the most accessed papers of 2020 for the Journal of the American Society for Mass Spectrometry.
https://cancer.ufl.edu/2021/02/24/uf-health-cancer-center-researchers-developing-new-cancer-immunotherapy-drug/…
An assistant professor is named someone to watch in 2021 for her groundbreaking research on lupus. UF’s Erika Moore was recently named to Forbes magazine’s 30 Under 30 health care experts to watch in 2021. The 29-year-old Rhines Rising Star and Larry Hench endowed assistant professor of…
Link to article: https://ufhealth.org/news/2020/existing-antihistamine-drugs-show-effectiveness-against-covid-19-virus-cell-testing…
Link to article: https://www.wcjb.com/2020/12/04/uf-health-doctors-looking-into-allergy-medications-that-could-prevent-catching-covid-19/ …
Fredenburg to head CTSI Biorepository…
The grant titled, ‘Developing a novel PROTAC-based NR4A1 degrader for breast-cancer therapy’ will focus on revolutionizing treatment regimens by replacing them with ones that are more effective, less toxic, and impact survival. This is a partnering PI option with Dr. Zheng, Guangrong; co-investigators: Dr. Zhou, Daohong, Dr. Bacher, Rhonda and…
